Diagnosis of medication and clinical services for chronic metabolic diseases: a survey of pharmaceutical services in Shaoxing City based on the medical alliance model

Background: Hierarchical medical treatment is the core system of China's medical reform. The medical alliance model, as an important carrier, has been promoted nationwide. Purpose: This study aims to comprehensively assess the current status of pharmaceutical services in the medical alliance of Shaoxing City, with a focus on the application of metabolic abnormality tests, providing a basis for improving service homogeneity. Methods: The study adopted the cross-sectional survey method. Questionnaires were distributed to the heads of the pharmacy departments of 4 general hospitals of the medical alliance and 23 branch hospitals in Shaoxing from April to May 2021. Discussion: Measures such as optimising the allocation of testing resources, improving unified standards and mutual recognition mechanisms, and strengthening the collaboration between testing and pharmaceutical services should be taken to enhance the homogenisation level of metabolic abnormality tests, thereby comprehensively improving the pharmaceutical service capabilities of the medical alliance and promoting implementation of hierarchical medical treatment.